300 related articles for article (PubMed ID: 38003333)
41. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.
Kotlyarov S; Kotlyarova A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563200
[TBL] [Abstract][Full Text] [Related]
42. Bioactive products formed in humans from fish oils.
Skarke C; Alamuddin N; Lawson JA; Li X; Ferguson JF; Reilly MP; FitzGerald GA
J Lipid Res; 2015 Sep; 56(9):1808-20. PubMed ID: 26180051
[TBL] [Abstract][Full Text] [Related]
43. Topical Administration of a Marine Oil Rich in Pro-Resolving Lipid Mediators Accelerates Wound Healing in Diabetic
Ontoria-Oviedo I; Amaro-Prellezo E; Castellano D; Venegas-Venegas E; González-Santos F; Ruiz-Saurí A; Pelacho B; Prósper F; Pérez Del Caz MD; Sepúlveda P
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077316
[TBL] [Abstract][Full Text] [Related]
44. Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors.
Keelan JA; Mas E; D'Vaz N; Dunstan JA; Li S; Barden AE; Mark PJ; Waddell BJ; Prescott SL; Mori TA
Reproduction; 2015 Feb; 149(2):171-8. PubMed ID: 25504868
[TBL] [Abstract][Full Text] [Related]
45. Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling.
Díaz Del Campo LS; Rodrigues-Díez R; Salaices M; Briones AM; García-Redondo AB
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408952
[TBL] [Abstract][Full Text] [Related]
46. Prolonged experimental sleep disturbance affects the inflammatory resolution pathways in healthy humans.
Engert LC; Mullington JM; Haack M
Brain Behav Immun; 2023 Oct; 113():12-20. PubMed ID: 37369338
[TBL] [Abstract][Full Text] [Related]
47. Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination.
Norling LV; Serhan CN
J Intern Med; 2010 Jul; 268(1):15-24. PubMed ID: 20497301
[TBL] [Abstract][Full Text] [Related]
48. The need for precision nutrition, genetic variation and resolution in Covid-19 patients.
Simopoulos AP; Serhan CN; Bazinet RP
Mol Aspects Med; 2021 Feb; 77():100943. PubMed ID: 33551236
[TBL] [Abstract][Full Text] [Related]
49. Distinct Profiles of Specialized Pro-resolving Lipid Mediators and Corresponding Receptor Gene Expression in Periodontal Inflammation.
Ferguson B; Bokka NR; Maddipati KR; Ayilavarapu S; Weltman R; Zhu L; Chen W; Zheng WJ; Angelov N; Van Dyke TE; Lee CT
Front Immunol; 2020; 11():1307. PubMed ID: 32670289
[TBL] [Abstract][Full Text] [Related]
50. Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?
Schebb NH; Kühn H; Kahnt AS; Rund KM; O'Donnell VB; Flamand N; Peters-Golden M; Jakobsson PJ; Weylandt KH; Rohwer N; Murphy RC; Geisslinger G; FitzGerald GA; Hanson J; Dahlgren C; Alnouri MW; Offermanns S; Steinhilber D
Front Pharmacol; 2022; 13():838782. PubMed ID: 35308198
[TBL] [Abstract][Full Text] [Related]
51. Development of an Optimized LC-MS Method for the Detection of Specialized Pro-Resolving Mediators in Biological Samples.
Kutzner L; Rund KM; Ostermann AI; Hartung NM; Galano JM; Balas L; Durand T; Balzer MS; David S; Schebb NH
Front Pharmacol; 2019; 10():169. PubMed ID: 30899221
[TBL] [Abstract][Full Text] [Related]
52. Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis.
Eickmeier O; Fussbroich D; Mueller K; Serve F; Smaczny C; Zielen S; Schubert R
PLoS One; 2017; 12(2):e0171249. PubMed ID: 28158236
[TBL] [Abstract][Full Text] [Related]
53. Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators.
Serhan CN
J Thromb Haemost; 2009 Jul; 7 Suppl 1():44-8. PubMed ID: 19630766
[TBL] [Abstract][Full Text] [Related]
54. Formation of lipoxins and resolvins in human leukocytes.
Kahnt AS; Schebb NH; Steinhilber D
Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106726. PubMed ID: 36878381
[TBL] [Abstract][Full Text] [Related]
55. [Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids].
Nowak JZ
Postepy Hig Med Dosw (Online); 2010 Mar; 64():115-32. PubMed ID: 20354260
[TBL] [Abstract][Full Text] [Related]
56. The biosynthetic pathways of the protectins.
Stenvik Haatveit Å; Hansen TV
Prostaglandins Other Lipid Mediat; 2023 Dec; 169():106787. PubMed ID: 37806439
[TBL] [Abstract][Full Text] [Related]
57. Effects of postnatal omega-3 fatty acid supplementation on offspring pro-resolving mediators of inflammation at 6 months and 5 years of age: A double blind, randomized controlled clinical trial.
See VHL; Mas E; Prescott SL; Beilin LJ; Burrows S; Barden AE; Huang RC; Mori TA
Prostaglandins Leukot Essent Fatty Acids; 2017 Nov; 126():126-132. PubMed ID: 29031390
[TBL] [Abstract][Full Text] [Related]
58. Specialized Pro-Resolving Mediators from Omega-3 Fatty Acids Improve Amyloid-β Phagocytosis and Regulate Inflammation in Patients with Minor Cognitive Impairment.
Fiala M; Terrando N; Dalli J
J Alzheimers Dis; 2015; 48(2):293-301. PubMed ID: 26401996
[TBL] [Abstract][Full Text] [Related]
59. Resolution of inflammation: An organizing principle in biology and medicine.
Panigrahy D; Gilligan MM; Serhan CN; Kashfi K
Pharmacol Ther; 2021 Nov; 227():107879. PubMed ID: 33915177
[TBL] [Abstract][Full Text] [Related]
60. Specialized pro-resolving lipid mediators in endodontics: a narrative review.
Aubeux D; Peters OA; Hosseinpour S; Tessier S; Geoffroy V; Pérez F; Gaudin A
BMC Oral Health; 2021 May; 21(1):276. PubMed ID: 34030680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
